Clinical Trial Update: Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating 18-Methoxycoronaridine for efficacy, safety, and tolerability in cutaneous leishmaniasis is underway but status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leishmaniasis

Drugs mentioned

• 18-Methoxycoronaridine (18-Methoxycoronaridine)

Snippet

Sponsor: Infan Industria Quimica Farmaceutica Nacional | Conditions: Leishmaniasis; American, Cutaneous, Drug Side Effect | Phase 2 | Status: UNKNOWN